Evgen Limited

Development of a novel anti-cancer agent, Sulforadex. Now in Phase I, it is initially being developed for prostate and breast cancer.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Liverpool, England, GB
  • Currency GBP
  • Founded January 2008
  • Employees 4
  • Website evgen.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free